(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-SIGLEC-7 PARA O TRATAMENTO DO CÂNCER E MÉTODOS PARA OBTENÇÃO DOS MESMOS

ArquivadaInvention PatentPCT · US2017045641

Application data

Number

112019002331

Type

Invention Patent

Filing

08/04/2017

Publication

06/18/2019

PCT

US2017045641

Progress at the INPI

  1. Filing08/04/17
  2. Publication06/18/19
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/09/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ALLAKOS INC.

US

See this company's full portfolio

Inventors

C. B. (pessoa física)

US

K. L. (pessoa física)

US

N. T. (pessoa física)

US

S. B. (pessoa física)

US

W. K. (pessoa física)

US

Technical data

Priority claims

US

62/371,680 · 08/05/2016

Abstract

A invenção provê métodos e composições para o tratamento de câncer usando anticorpos anti-siglec-7.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

07/09/2024

RPI 2792

Parecer de pré-exame

#6.23

02/20/2024

RPI 2772

Adição na publicação

#15.35

10/05/2021

RPI 2648

Notificação de entrada na fase nacional - PCT

#1.3

06/18/2019

RPI 2528

Alteração de dados cadastrais

#1.1

02/12/2019

RPI 2510

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.